GameStop Corp. vs Hims and Hers Health Inc — how do they compare? GameStop Corp. trades at $26.56 (market cap $12.75B), while Hims and Hers Health Inc trades at $30.92 (market cap $6.55B). The key difference: GameStop Corp. is the larger of the two by market cap, and GameStop Corp. is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 62 Days and Hims and Hers Health Inc for 21 Days on average.
| GME | HIMS | |
|---|---|---|
Market Cap | $12.75B | $6.55B |
Volume | 13,026,993 | 14,842,814 |
Sector | Consumer Cyclical | Health |
52-Week High | $26.56 | $62.76 |
52-Week Low | $17.87 | $14.52 |
Typical Hold Time | 62 Days | 21 Days |
Enterprise Value | $12.03B | $7.25B |
Signals from Pluang's Aura AI — not financial advice
GME trades at $25.28, up 2.85% today, with a bullish technical signal from moving averages and strong insider buying by CEO Ryan Cohen. The company reported net income of $131.3 million in 2025, a significant turnaround from prior losses, and holds a robust cash position of $4.77 billion. Recent earnings beat expectations in two of the last three quarters, though revenue has declined from $6.0 billion in 2022 to $3.8 billion in 2025.
The outlook is mixed: strong cash reserves and insider confidence support upside, but declining revenue and a high P/E ratio of 16.63 pose risks. Analyst consensus is cautious with only 16.67% buy ratings. Key risks include execution challenges in the retail sector and reliance on insider sentiment rather than fundamental growth.
HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.
The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →